Gadolinium news

All news on Gadolinium: plants, production capacities, investments and involved companies in Europe.

10 July 2025
Bayer Seeks EU Approval for Gadoquatrane
Gadoquatrane, a low-dose MRI contrast agent, shows positive Phase III results. EU approval could reduce gadolinium exposure by 60% compared to current standards.

Who will be producing Gadolinium in the future?

Find out with chemXplore Analytics